BLACK mobile logo

california

community

Zambia Blasts the US Over a $2 Billion Health Deal in Exchange for Critical Minerals

May 18, 2026

The United States is restructuring its foreign aid approach in Africa under the Trump administration's "America First" policy, replacing traditional programs like PEPFAR with transactional bilateral agreements that tie health funding to conditions including access to sensitive health data, biological samples, and commercial provisions. Zambia's foreign affairs minister has publicly accused the U.S. of linking a $2 billion health assistance deal to preferential access to the country's critical minerals, while the outgoing U.S. ambassador has countered by alleging corruption and government inaction. Several African nations, including Ghana, Zimbabwe, and Kenya, have either rejected proposed deals or put them on hold due to concerns about data privacy, lack of guarantees for accessing vaccines or treatments developed from shared data, and insufficient transparency in closed-door negotiations.

Who is affected

  • African nations negotiating health deals: Zambia, Ghana, Zimbabwe, Kenya, Lesotho, and approximately 30 other countries
  • Citizens of these countries who depend on U.S. health assistance programs
  • Zambian government officials accused of corruption by U.S. Ambassador Michael Gonzales
  • U.S. Ambassador Michael Gonzales (outgoing)
  • Zambian Foreign Affairs Minister Mulambo Haimbe
  • Countries previously supported by USAID and PEPFAR programs
  • China, as a competing strategic partner in Africa
  • The World Health Organization
  • Health advocacy groups (Health GAP, Southern Africa Litigation Center, KFF)

What action is being taken

  • The Trump administration is negotiating country-by-country health agreements with African nations
  • Zambia and the U.S. are continuing negotiations over a $2 billion health deal
  • Kenya has put its $2.5 billion agreement on hold following a court challenge
  • African governments are pushing back against U.S. demands for health data and biological samples
  • The U.S. is pursuing direct bilateral disease surveillance channels after withdrawing from the WHO

Why it matters

  • This represents a fundamental transformation in U.S.-Africa relations and global health governance, shifting from humanitarian aid to transactional diplomacy that conditions life-saving health assistance on commercial and political concessions. The approach undermines multilateral health coordination through the WHO and risks creating a fragmented global health system that could weaken pandemic preparedness and response. African nations face an impossible choice between accepting deals with potentially exploitative terms—including surrendering sensitive citizen health data without guarantees of accessing resulting medical innovations—or losing critical funding for already strained health systems. The situation recalls COVID-19 inequities when African countries contributed data but were last to receive vaccines, and it intensifies U.S.-China competition over Africa's strategic mineral resources needed for green energy technology, with health funding becoming leverage in that geopolitical contest.

What's next

  • Negotiations between Zambia and the U.S. are expected to continue regarding the $2 billion health deal
  • Kenya's court challenge to its $2.5 billion agreement will proceed through the legal system
  • The WHO is negotiating new frameworks on pathogen-sharing and equitable access to vaccines (though the U.S. is not participating after its January withdrawal)
  • Countries with signed agreements must meet domestic health spending targets or risk losing U.S. aid

Read full article from source: The San Diego Voice & Viewpoint